570 related articles for article (PubMed ID: 26289975)
1. Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.
Isakova-Sivak I; Rudenko L
Expert Rev Vaccines; 2015; 14(10):1313-29. PubMed ID: 26289975
[TBL] [Abstract][Full Text] [Related]
2. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
Rudenko L; Isakova-Sivak I
Expert Rev Vaccines; 2015 Mar; 14(3):395-412. PubMed ID: 25555687
[TBL] [Abstract][Full Text] [Related]
3. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
4. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
6. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
Rudenko L; Yeolekar L; Kiseleva I; Isakova-Sivak I
Vaccine; 2016 Oct; 34(45):5436-5441. PubMed ID: 27593158
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.
Coelingh K; Olajide IR; MacDonald P; Yogev R
Expert Rev Vaccines; 2015; 14(10):1331-46. PubMed ID: 26372891
[TBL] [Abstract][Full Text] [Related]
8. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
[TBL] [Abstract][Full Text] [Related]
9. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
Rudraraju R; Mordant F; Subbarao K
J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
[No Abstract] [Full Text] [Related]
10. Development of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.
Cox A; Baker SF; Nogales A; Martínez-Sobrido L; Dewhurst S
J Virol; 2015 Mar; 89(6):3421-6. PubMed ID: 25552727
[TBL] [Abstract][Full Text] [Related]
11. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC
Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036
[TBL] [Abstract][Full Text] [Related]
13. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
[TBL] [Abstract][Full Text] [Related]
15. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
[TBL] [Abstract][Full Text] [Related]
16. [Live attenuated and inactivated influenza vaccines: data from direct comparative studies].
Kashirina OS; Vasil'ev IuM
Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):103-19. PubMed ID: 24738303
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
[TBL] [Abstract][Full Text] [Related]
18. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
Rudenko L; Kiseleva I; Naykhin AN; Erofeeva M; Stukova M; Donina S; Petukhova G; Pisareva M; Krivitskaya V; Grudinin M; Buzitskaya Z; Isakova-Sivak I; Kuznetsova S; Larionova N; Desheva J; Dubrovina I; Nikiforova A; Victor JC; Neuzil K; Flores J; Tsvetnitsky V; Kiselev O
PLoS One; 2014; 9(2):e87962. PubMed ID: 24533064
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children.
Block SL; Falloon J; Hirschfield JA; Krilov LR; Dubovsky F; Yi T; Belshe RB
Pediatr Infect Dis J; 2012 Jul; 31(7):745-51. PubMed ID: 22466322
[TBL] [Abstract][Full Text] [Related]
20. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.
King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M;
Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
